Nanotechnology : Tucson

CRN conference: Challenges & Opportunities: The Future of Nano & Bio Technologies

Benj — Tue, 10 Jul 2007 11:12:11 +0000

Short description

An Interdisciplinary Conference organized by World Care and the Center for Responsible Nanotechnology. They will hold the first interdisciplinary conference on the development of molecular manufacturing and its relationship to emerging biotechnologies.

Long description

Challenges & Opportunities: The Future of Nano & Bio Technologies, to be held September 9-13, 2007 at the Radisson Hotel and Suites in Tucson, will feature a distinguished roster of speakers from leading biotechnology and nanotechnology organizations and universities.

Presenters will discuss both technical details and the larger meaning of their work, and attendees will have multiple opportunities for open dialog with the speakers.

Day one of the conference will focus on biotechnology, including both the underlying science and key applications. Day two will focus on nanotechnology, with an emphasis on the path to molecular manufacturing. Day three will look at the societal and environmental implications of nano/bio manufacturing. On the fourth day there will be assisted tours of Tucson area biotech and nanotech facilities.

The program will feature speakers covering a number of topics including: Tuberculosis and Bird Flu - New Epidemics in 2007; How to Build a Nanofactory; Military, Security, and Surveillance Issues; and more.

"With this conference, we aim to provide education and interaction regarding the relationship between early generation nanotechnology and biotechnology and how each discipline might lead toward a future of exponential general-purpose molecularly-precise manufacturing," said Mike Treder, Executive Director, Center for Responsible Nanotechnology. "The world is not yet fully aware of all the societal and environmental consequences that may await us."

CRN will also make available for review and debate a series of future scenarios created by the organization's Global Task Force on Implications and Policy. More than 50 people from six continents, with a range of backgrounds and points of view, worked together to develop professional-quality models of a world in which molecular manufacturing becomes a reality. This will be the first public opportunity for assessing and responding to those scenarios.

Event precise location and contact information

Radisson Hotel and Suites, Tucson, Arizona

Call 520-514-1588 from 9:00 am to 3:00 pm (MST) Monday-Friday – Credit card registrations only

Web site Url link

http://www.crnano.org/conf2007.htm

Web site Url text

http://www.crnano.org/conf2007.htm

Fullerene International Corporation

Benj — Fri, 25 Aug 2006 13:06:54 +0000

Ticker Id

Web url

http://www.fullereneinternational.com/

Contact Email

info@fullereneinternational.com

Short description

Street address

7960 S. Kolb Rd.

Zip or postal code

85706

Telephone

520.574.6534

Fax

520.574.1983

Foundation date

Ceo, president

1999-12

Number of employees

Long description

Additional Commentaries and remarks

Patents

Materials and Electrochemical Research Corporation ( MER )

Benj — Thu, 24 Aug 2006 15:41:24 +0000

Ticker Id

Web url

http://www.mercorp.com/

Contact Email

mercorp@mercorp.com

Short description

Street address

7960 S. Kolb Rd.

Zip or postal code

85706

Telephone

520 574 1980

Fax

520 574 1983

Foundation date

Ceo, president

Number of employees

Long description

Materials and Electrochemical Research (MER) Corporation is devoted to high technology materials and electrochemical research and development with emphasis on advanced composites, powders, coatings and fullerenes as well as energy conversion systems that include batteries, fuel cells, and gas storage. MER was started in 1985 with SBIR contracts as its primary business. In 1986, MER entered into a joint venture with a foreign international chemical corporation with MER as the managing partner to commercialize aluminum nitride ceramics. After building the joint venture into a research, development and production operation, MER sold its interest to Montedison in mid 1988. MER has built state-of-the-art research, development and small-scale production facilities for performing contract R&D and production demonstrations. Extensive cooperative efforts between major universities and international corporations have been a hallmark of MER's research and development activities.

MER continues to emphasize SBIR contract activities as well as to explore opportunities to commercialize the developed technologies in advanced composites, powders, coatings, reinforcements, fullerenes and energy conversion systems. MER excels in innovative solutions to material development problems and has been a leader in translating these solutions to commercial applications.

Additional Commentaries and remarks

Patents

ADE Phase Shift

Benj — Tue, 22 Aug 2006 19:43:51 +0000

Ticker Id

Web url

http://www.phase-shift.com/

Contact Email

Short description

Street address

3470 E. Universal Way

Zip or postal code

85706

Telephone

(520) 573-9250

Fax

(520) 573-9355

Foundation date

Ceo, president

Number of employees

Long description

ADE Phase Shift is a wholly owned subsidiary of ADE Corporation (Nasdaq: ADEX). As a company we design and build high precision systems for measuring the flatness, roughness and shape of advanced technology surfaces.

ADE Phase Shift was founded in Tucson as Phase Shift Technology, Inc. in 1987, by Chris Koliopoulos, Ph.D. and David Basila. The company soon offered a variety of interferometry-based products, including fringe analysis software, laser-based Fizeau interferometers, and microscope-based white light interferometers.
Interferometers use the natural wave properties of light, reflected from a surface to be tested, to map the tiniest surface height variations. Using interferometry, telescope mirror manufacturers gauge the quality and focus of their mirrors, and disk drive manufacturers make sure the platters used in computer disk drives are flat enough to withstand the high speeds and close quarters of the interior of a computer drive. It was Phase Shift interferometers that were used by the company that made the lenses that fixed the orbital Hubble telescope's blurred vision.

In 1998, Phase Shift Technology merged with Massachusetts-based ADE Corporation, a manufacturer of metrology equipment for the semiconductor and data storage industries. Since that time, the company has been called ADE Phase Shift.

ADE Phase Shift now makes products with applications for the measuring of the surface topology of polished silicon wafers, as well as systems for measuring critical surfaces in the hard disk industry, and many needs of optics manufacturers.

Additional Commentaries and remarks

Patents

Tailored Materials Corporation Inc. (TMC)

Benj — Fri, 18 Aug 2006 12:29:56 +0000

Ticker Id

Web url

http://www.tmcnanotech.com/

Contact Email

Short description

Street address

7960 South Kolb Road

Zip or postal code

85706

Telephone

(520) 574-1980 ext. 201

Fax

(520) 574-1983

Foundation date

Ceo, president

Number of employees

Long description

TMC addresses critical needs in CNT applications: high selectivity and reproducible purity, for optimum, tailored, mechanical and electronic properties. The breakthrough employs proprietary knowledge of nanotube formation processes, promising large-scale manufacture of high quality DWNT.

TMC plans to sell product to major US and global display and device vendors. Double-wall nanotubes -- which TMC's pending patent defines as nanotubes with two to five walls -- offer performance equal or better than single wall nanotubes (SWNT) for conduction and emission of electrons, but show significantly longer useful lifetimes, translating to more practical, cost-effective devices.

Application developers have been limited using CNT due to quality and availability constraints. TMC aims to serve billion dollar global markets in areas as diverse as batteries, solar cells, displays, medical imaging and diagnostics devices. Lab tests bode well both at TMC, and at facilities of potential customers to whom we provided samples. Compared to other nanotubes, DWNT require lower voltage to produce a given amount of current and have longer service lifetime two important plusses in TMC's target applications.

TMC licensed process and composition of matter patents pending from Fullerene International Corporation (FIC), and obtained equipment, experienced personnel and know-how from MER Corporation, that enable production of DWNT with true mass yield in the 90%+ purity range. MER first made fullerenes and nanotubes commercially, starting in 1992, and remains a leader in production and new applications R&D.

Additional Commentaries and remarks

Patents

ImaRx Therapeutics, Inc.

Benj — Wed, 16 Aug 2006 20:14:04 +0000

Ticker Id

Web url

http://www.imarx.com/

Contact Email

imarx@imarx.com

Short description

Street address

1635 East 18th Street

Zip or postal code

85719

Telephone

(520)770-1259

Fax

(520)791-2437

Foundation date

Ceo, president

Number of employees

Long description

ImaRx Therapeutics, Inc. is a pioneer in the medical applications of nanotechnology, e.g. NanoSurgery, with over 100 issued US patents. ImaRx’s lead NanoSurgery program, SonoLysis, a novel method for treating thrombosis (clots), is currently in clinical studies.

SonoLysis employs tiny microbubbles and nanobubbles, which are much smaller than a red blood cell, injected into the blood stream to enter into regions of thrombosis. When external ultrasound is applied, the microbubbles cavitate and dissolve blood clots into micron-sized and smaller particles. SonoLysis is designed to painlessly and safely restore blood flow to treat stroke, heart attack and other conditions.

ImaRx has developed broad nanotechnology platforms to improve patient care through targeted, site-selective therapy. These platforms are protected by patents and supported by NIH grants. Applications include gene and drug delivery to treat and diagnose vulnerable plaque, cardiovascular disease, cancer, and central nervous system disorders.